Friends, today we will talk about Laurus Labs Share Price Target 2024, 2025, 2026, 2027, 2030, 2035, 2040, and 2050 Stock Analysis. Today we will try to know in which direction the performance of this excellent company related to the pharmaceutical industry has the potential to go in the coming years. Due to the kind of growth that has been seen in this industry in the last few years, investors are also expecting good growth in the business of Laurus Labs in the coming years.
Today, along with analyzing the complete details of the business of Laurus Labs, we will also take a good look at the business opportunities of the company, which will give us some idea of how much Laurus Labs Share Price Target has the potential to show in the coming years. Let us analyze in detail:
Laurus Labs Share Price Target 2024
Laurus Labs is a fully integrated pharmaceutical and biotechnology company that develops and manufactures medicines for many major diseases. The company mainly operates within four business categories, which include APIs, Synthesis, Formulation, and BIO. If we look at all these business categories, in the last few years, the company has been successful in showing very good growth in the APIs and Synthesis segments.
In the coming days, Laurus Labs seems to be gradually focusing more on diversifying its business portfolio. A few years ago, most of the company’s business came from the APIs segment; now, if we look at the other segments as well, the company seems to be getting very good revenue. As the revenue segment of the company increases in the coming days, the company’s business is going to see good profits.
As the company’s business portfolio gets diversified, if we look at Laurus Labs Share Price Target till 2024, there is full hope of earning very good returns and showing you the first target of Rs 450. As soon as this target is achieved, you will soon see another target of Rs. 470.
Laurus Labs Share Price Target 2024 Table
Year | Laurus Labs Share Price Target 2024 |
---|---|
First Target 2024 | Rs 450 |
Second Target: 2024 | Rs 470 |
Laurus Labs Share Price Target 2025
With the help of its good connections with the best multinational pharma companies, Laurus Labs has been successful in creating a strong presence in the global market. Talking about connections, many big companies like Aurobindo Pharma, Mylam, Natco, Cipla, Sun Pharma, and many other pharma companies are involved with Laurus Labs. Due to the long-standing good relationship with the customers, they are seen in the market. So the company has succeeded in establishing very good brand value in its sector.
If we also look at the future, the management is completely focused on expanding its presence in new markets around the world with the help of its excellent connections. As Laurus Labs continues to expand its presence in different new markets around the world, it can be expected that the company’s business will also grow accordingly.
With the growth of the company’s business in the worldwide market, if we look at the Laurus Labs Share Price Target till 2025, the first target can be seen showing Rs 530 along with earning very good returns. After that, you can definitely look at the second target of interest at Rs 560.
Laurus Labs Share Price Target 2025 Table
Year | Laurus Labs Share Price Target 2025 |
---|---|
First Target: 2025 | Rs 530 |
Second Target: 2025 | Rs 560 |
Laurus Labs Share Price Target 2026
In view of the ever-increasing demand for pharmaceutical products in the global market, the company is continuously increasing its manufacturing capacity. Currently, Laurus Labs has six manufacturing facilities that have approval from big organizations like WHO, USFDA, PMDA, NIP, KFDA, and BfArM. Due to offering better-quality products to its customers, the demand for the company’s products seems to be increasing rapidly.
To meet the ever-increasing demand for pharmaceutical products in the market, Laurus Labs is planning to expand its existing manufacturing capacity as well as develop a new modern manufacturing facility in the coming years. As Laurus Labs continues to increase its capacity to meet the market demand, the company will definitely see benefits in its business.
As the company increases its production capacity, Laurus Labs Share Price Target is expected to show excellent growth till 2026 and the first target will be Rs 640. And then you can definitely think of holding the second target for Rs 660.
Laurus Labs Share Price Target 2026 Table
Year | Laurus Labs Share Price Target 2026 |
---|---|
First Target 2026 | Rs 640 |
Second Target: 2026 | Rs 660 |
Laurus Labs Share Price Target 2027
For any pharmaceutical industry, it becomes most important to strengthen its R&D to maintain growth in its business. If we look at the R&D of Laurus Labs, it appears to be very strong, in which about 750+ scientists work, which is one fourth of the total number of employees of the company, to manage which the company has to keep making huge investments every year.
In the last few years, Laurus Labs, with the help of its strong R&D, has filed around 322 patents, out of which around 184 are currently available with the company. To further strengthen its R&D, the company seems to be planning to invest a good amount in the coming years, which will help the company make new innovations very easily and improve the quality of its products. Are.
In the coming years, as the company’s R&D will become stronger, if we look at Laurus Labs Share Price Target till 2027, then along with earning very good returns, the first target is expected to be around Rs 750. After achieving this target, you will soon see another target of Rs. 800.
Laurus Labs Share Price Targets 2027 Table
Year | Laurus Labs Share Price Target 2027 |
---|---|
First Target 2027 | Rs 750 |
Second Target: 2027 | Rs 800 |
Laurus Labs Share Price Target 2030
Even if seen in the long run, India is gradually becoming a hub in the pharmaceutical industry, which a few years ago was the largest exporter of pharmaceutical products to China, but since the pandemic, most of the countries are importing their pharmaceutical products from China. As an alternative to buying, most of these products are seen being bought from India itself, due to which Indian-origin companies like Laurus Labs are seen getting very good benefits.
At the same time, the Government of India is also seen to be providing good facilities under different schemes to the domestic manufacturing companies to make themselves self-reliant, due to which Laurus Labs is taking maximum advantage of the government schemes and making huge profits in its business. It seems to be working as per the strategy, which is going to help the company grow its business in the coming time.
Keeping in mind the growing opportunities of business in the long run, if we look at Laurus Labs Share Price Target till 2030, there is every possibility of giving very good returns to the shareholders and showing the share price around Rs 1800.
Laurus Labs Share Price Targets 2030 Table
Year | Laurus Labs Share Price Target 2030 |
---|---|
First Target: 2030 | Rs 860 |
Second Target: 2030 | Rs 980 |
Laurus Labs Share Price Target 2024, 2025, 2026, 2027, 2030, 2035, 2040, 2050 Table
Year | Laurus Labs Share Price Target |
---|---|
First Target 2024 | Rs 450 |
First Target: 2025 | Rs 470 |
First Target 2026 | Rs 530 |
First Target: 2027 | Rs 560 |
First Target: 2030 | Rs 640 |
First Target: 2035 | Rs 660 |
First Target 2040 | Rs 750 |
First Target: 2050 | Rs 800 |
Laurus Labs Share Price Target 2024, 2025, 2026, 2027, 2030, 2035, 2040, 2050 Table
Future of Laurus Labs Share
In the future, to maintain the growth of its business, Laurus Labs is continuously expanding its product portfolio and adding more to it. As the company’s product portfolio expands in the coming years, the business will increase accordingly. You are also going to see huge growth.
Along with this, Laurus Labs is seen making a lot of contributions to expanding the reach of its business across the world by collaborating with other big companies related to its sector. The management seems to be investing a lot in expanding the reach of its business in big markets around the world as well as in underdeveloped countries, the benefits of which Laurus Labs will definitely see in the future.
Risk of Laurus Labs Share
Talking about the biggest risk in the business of Laurus Labs, being associated with the pharmaceutical industry, the company has to face many rules and regulations from different countries. If any of the company’s products are seen getting rejected for approval, then it may have a significant impact on the company’s business in the future too.
Speaking of the second risk, Laurus Labs has to import all the raw materials required to make its pharmaceutical products from outside countries. If any problem is seen with the import of raw materials in the coming time, then it can have a huge impact on the business of the company; however, the management seems to be gradually adopting new strategies in its business to reduce the import of raw materials. Are.
my opinion:-
There is no doubt that the way Laurus Labs is continuously launching new products in each of its business categories to strengthen itself in the pharmaceutical industry, the company is definitely benefiting from it in the long run. Is coming.
If you are a long-term investor and want to take advantage of the ever-increasing growth of the pharma sector, then Laurus Labs appears to be a very good company in my view. But keep in mind that before taking any decision related to investment, do not forget to analyze the complete details of the company’s business yourself or take the advice of your financial advisor.
F.A.Q. Laurus Labs Share
Is Laurus Labs a good buy now?
On Laurus Labs, ten analysts have started writing articles. Four analysts have given it a buy recommendation, and one analyst has given it a strong buy rating. The stock has received a sell rating from 0 analysts. In the most recent quarter, the company had a net profit of 23.14 crores.
What is the target of Laurus Labs share in 2024?
Based on technical data, the projected minimum and maximum share prices for LAURUSLABS in 2024 are ₹444.36 and ₹488.95, respectively.
What are the future prospects of Laurus Labs?
Prospective Development Revenue and earnings growth for Laurus Labs are anticipated to increase by 14.3% and 49.7% year, respectively. The predicted annual growth rate for EPS is 50%. In three years, the return on equity is expected to be 16.6%.
Is Laurus Labs good for long term?